Register now for our upcoming webinar
The website is organised and funded by PTC Therapeutics for healthcare professionals in Middle East and Africa
Consultant Pediatric Neurology
Dr. Tabarki completed his medical school at University of Tunisia and his residencies in pediatrics, pediatric neurology, and neurophysiology at Paris V University, France, and UCL-Brussels, Belgium. His currently consultant pediatric neurology at Prince Sultan Military Medical City, Riyadh, Saudi Arabia, clinical tutor pediatric neurology residency program, and adjunct Professor.
His fields of clinical and research interest include pediatric movement disorders, neurometabolic and neurodegenerative disorders, especially Biotin-thiamine responsive basal ganglia disease, pyridoxine dependent epilepsy, leukodystrophy, and neurotransmitter biosynthesis defects. Academic teaching contributions include international courses and research focused on the same disorders, leading to numerous publications. He is a member of the editorial boards of Frontiers pediatric neurology, and Neurosciences
Consultant Pediatric Neurologist
Dr. Abukhaled is a Pediatric neurologist with speciality in stroke and epilepsy.
Dr. Abukhaled is the section head of Pediatric neurology at King Faisal Specialist Hospital and Research Centre and assistant professor in Alfaisal University.
Consultant Pediatric Neurologist
Dr Gacía-Cazorla is a child neurologist with specific background in metabolism and rare genetic conditions, trained at Hospital Sant Joan de Déu (HSJD), Barcelona, Hôpital Necker, Paris, and Columbia University, NY. She founded the “Synaptic metabolism laboratory” in 2009 at HSJD and since then she has combined both, clinical activity as a child neurologist and head of the neurometabolic unit, and basic investigation. She co-founded the I-NTD, a worldwide network for the study of neurotransmitter-related diseases. She is currently the coordinator of the subgroup NOMPs (neurotransmitter and other neurometabolic diseases) at the metabERN (European Reference Network).
She is a member of diverse Scientific Commitees: Recordati Rare Diseases Foundation, E-IMD, I-NTD, European Glut1D association. She is a member of the board of directors of the SSIEM.
She has published more than 200 impact factor articles about clinical descriptions, pathophysiology and biomarkers of diverse diseases including the description of new disorders.
https://pubmed.ncbi.nlm.nih.gov/?term=garcia+cazorla&sort=date
GET EXPERIENCE
How you transform your business as technology, consumer, habits industry dynamic s change? Find out from those leading the charge.
21:00–21:05
21:10–21:35
21:35 - 22:00
21:00–21:10
21:10–21:40
21:40 - 22:10
21:10–21:40
21:40–22:10
219
How you transform your business as technology, consumer, habits industrys dynamic
Buy Ticket
399
How you transform your business as technology, consumer, habits industrys dynamic
Buy Ticket
699
How you transform your business as technology, consumer, habits industrys dynamic
Buy Ticket
The website is organised and funded by PTC Therapeutics for healthcare professionals only
© 2021 PTC Therapeutics. All rights reserved.
This website is provided for healthcare professionals residing in the Middle East and Africa.
This educational website provides information to support the early and accurate diagnosis of rare neurotransmitter disorders, including Aromatic L-amino Acid Decarboxylase (AADC) deficiency.
